Format

Send to

Choose Destination
Nat Commun. 2015 Aug 3;6:7928. doi: 10.1038/ncomms8928.

Quantitative interactome analysis reveals a chemoresistant edgotype.

Author information

1
Department of Genome Sciences, University of Washington, Seattle, Washington 98195, USA.
2
Department of Pharmaceutical Sciences, Himeji Dokkoyo University, Himeji, Hyogo 670-8524, Japan.

Abstract

Chemoresistance is a common mode of therapy failure for many cancers. Tumours develop resistance to chemotherapeutics through a variety of mechanisms, with proteins serving pivotal roles. Changes in protein conformations and interactions affect the cellular response to environmental conditions contributing to the development of new phenotypes. The ability to understand how protein interaction networks adapt to yield new function or alter phenotype is limited by the inability to determine structural and protein interaction changes on a proteomic scale. Here, chemical crosslinking and mass spectrometry were employed to quantify changes in protein structures and interactions in multidrug-resistant human carcinoma cells. Quantitative analysis of the largest crosslinking-derived, protein interaction network comprising 1,391 crosslinked peptides allows for 'edgotype' analysis in a cell model of chemoresistance. We detect consistent changes to protein interactions and structures, including those involving cytokeratins, topoisomerase-2-alpha, and post-translationally modified histones, which correlate with a chemoresistant phenotype.

PMID:
26235782
PMCID:
PMC4532879
DOI:
10.1038/ncomms8928
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center